Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys

Metabolism: Clinical and Experimental

Volumn 52, Issue 9, 2003, Pages 1085-1091

  Shadoan, Melanie K ^a   Anthony, Mary S ^a   Rankin, Samuel E ^a   Clarkson, Thomas B ^a   Wagner, Janice D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CARBOHYDRATE; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; FRUCTOSAMINE; GLUCOSE; HORMONE DERIVATIVE; INSULIN; MEDROXYPROGESTERONE ACETATE; TIBOLONE;

ABDOMEN; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; HOMEOSTASIS; HORMONE SUBSTITUTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LOW DRUG DOSE; LUMBAR VERTEBRA; MONKEY; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOFT TISSUE;

EID: 0141682449     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00181-1     Document Type: Article

References (79)

1. Ley CJ, Lees B, Stevenson JC: Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 55:950-954, 1998
2. Tchernof A, Poehlman ET: Effects of the menopause transition on body fatness and body fat distribution. Obes Res 6:246-254, 1998
3. Nabulsi AA, Folsom AR, White A, et al: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069-1075, 1993
4. Lindheim SR, Buchanan TA, Duffy DM, et al.: Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and frequently sampled intravenous glucose tolerance test. J Soc Gynecol Invest 1:150-154, 1994
5. Wagner JD, Martino MA, Jayo MJ, et al: The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metabolism 45:1254-1262, 1996
6. Wagner JD, Cefalu WT, Anthony MS, et al: Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46:698-705, 1997
7. Wade GN: Gonadal hormones and behavioral regulation of body weight. Physiol Behav 8:523-534, 1972
8. Haarbo J, Marslew U, Gotfredsen A, et al: Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40:1323-1326, 1991
9. Espeland MA, Stefanick ML, Kritz-Silverstein D, et al: Effect of postmenopausal hormone therapy on body weight and waist and hip girths. J Clin Endocrinol Metab 82:1549-1556, 1997
10. Lindheim SR, Presser SC, Ditkoff EC, et al: A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Menopause 60:664-667, 1993
11. Galletti F, Klopper A: The effect of progesterone on the quantity and distribution of body fat in the female rat. Acta Endocrinol 46:379-386, 1964
12. Hervey E, Hervey GR: The effects of progesterone on body weight and composition in the rat. J Endocrinol 37:361-381, 1967
13. Everson SA, Goldberg DE, Helmrich SP, et al: Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care 21:1637-1643, 1998
14. Cefalu WT, Wagner JD, Bell-Farrow AD, et al: The effect of hormonal replacement therapy on insulin sensitivity in surgically postmenopausal cynomolgus monkeys (Macaca fascicularis). Am J Obstet Gynecol 171:440-445, 1994
15. Espeland MA, Hogan PE, Fineberg SE, et al: Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 21:1589-1595, 1998
16. Crespo CJ, Smit E, Snelling A, et al: Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: Results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 25:1675-1680, 2002
17. Ferrara A, Karter A, Glei D, et al: Hormone replacement therapy is associated with better glucose control in a multi-ethnic population with type 2 diabetes: The Northern California Kaiser Permanente diabetes registry. Diabetes 47:152, 1998 (suppl 1, abstr)
18. Lageder H: Carbohydrate metabolism and hormonal replacement therapy: Problems and clinical results. Acta Obstet Gynecol Scand 65:57-63, 1977
19. Spellacy WN, McLeod AGW, Buhi WC, et al: The effects of medroxyprogesterone acetate on carbohydrate metabolism: Measurements of glucose, insulin and growth hormone after twelve months' use. Fertil Steril 23:239, 1972
20. Kloosterboer HJ: Tibolone: A steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76:231-238, 2001
21. Moore RA: Livial: A review of clinical studies. Br J Obstet Gynaecol 106:1-21, 1999
22. McKerns KW, Coulomb B, Kaleita E, et al. Some effects of in vivo administered estrogens on glucose metabolism and adrenal cortical secretion in vitro. Endocrinology 63:709-722, 1958
23. Tsibris JC, Raynor LO, Buhi WC, et al: Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term. J Clin Endocrinol Metab 51:711-717, 1980
24. Spellacy WN, Buhi WC, Birk SA: The effects of norgestrel on carbohydrate and lipid metabolism over one year. Am J Obstet Gynecol 125:984-986, 1975
25. Clarkson TB, Anthony MS, Wagner JD: A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab 86:5396-5404, 2001
26. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
27. Katz A, Nambi SS, Albert P, et al: Quantitative insulin-sensitivity check index (QUICKI): A simple, accurate method for assessing insulin sensitivity in vivo. Diabetes 48:299, 1999 (suppl 1, abstr)
28. Feher MD, Cox A, Levy A, et al: Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes. Br J Obstet Gynaecol 103:281-283, 1996
29. Prelevic GM, Beljic T, Balint-Peric L, et al: Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus. Maturitas 28:271-276, 1998
30. De Aloysio D, Fabiani AG, Mauloni M, et al: Use of Org OD 14 for the treatment of climacteric complaints. Maturitas 1:49-65, 1987 (Suppl)
31. Hanggi W, Lippuner K, Jaeger P, et al: Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clin Endocrinol 48:691-699, 1998
32. Wallace JM, Shively CA, Clarkson TB: Effects of hormone replacement therapy and social stress on body fat distribution in surgically postmenopausal monkeys. Int J Obes Relat Metab Disord 23:518-527, 1999
33. Escalante Pulido JM, Alpizar SM: Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 30:19-22, 1999
34. Shively CA, Clarkson TB: Body Fat Distribution and Atherosclerosis, in Nonhuman Primate Studies on Diabetes, Carbohydrate Intolerance, and Obesity. New York, NY, Liss, 1988, pp 43-63
35. Albertazzi P, Di Micco R, Zanardi E: Tibolone: A review. Maturitas 30:295-305, 1998
36. Cagnacci A, Mallus E, Tuveri F, et al: Effect of tibolone on glucose and lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 82:251-253, 1997.
37. Sanchez-Chaparro MA, Parra A, Olalla MA, et al: Effects of tibolone on lipoproteins. Atherosclerosis 134:177, 1997 (suppl, abstr)
38. Wiegratz I, Starflinger F, Tetzloff W, et al: Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in post-menopausal women. Maturitas 41:133-141, 2001
39. Crona N, Silfverstolpe G, Samsioe G: A double-blind cross-over study on the effects of ORG OD14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women. Acta Endocrinol 102:451-455, 1983
40. Villanueva LA, Ortega R, Morimoto S, et al: Effects of tibolone on lipid and glucose metabolism as well as insulin secretion in postmenopausal women. Ginecol Obstet Mex 67:473-477, 1999
41. Saucedo RP, Basurto L, Fonseca E, et al: Effect of hormone replacement with tibolone on plasma insulin and blood glucose in postmenopause. Ginecol Obstet Mex 69:301-303, 2001
42. Wiegratz I, Sarflinger F, Tetzloff W, et al: Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women. Maturitas 41:133-141, 2002
43. Soranna L, Cucinelli F, Perri C, et al: Individual effect of E2 and dydrogesterone on insulin sensitivity in post-menopausal women. J Endocrinol Invest 25:547-550, 2002
44. Wagner JD, Thomas MJ, Williams JK, et al: Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol Metab 83:896-901, 1998
45. Hotamisligil GS, Peraldi P, Budavari A, et al: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996
46. Yamauchi T, Kamon J, Waki H, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
47. Steppan CM, Lazar MA: Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23, 2002
48. Friedman JE, Ishizuka T, Liu S, et al: Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol Endocrinol Metab 273:1014-1023, 1997
49. Lindheim SR, Duffy DM, Kojima T, et al: The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 62:1176-1180, 1994
50. Di Pirro R, Fusco A, Bertoli A, et al: Insulin receptors during the menstrual cycle in normal women. J Clin Endocrinol Metab 47:1387-1389, 1978
51. Tuttle S, Turkington VE: Effects of medroxyprogesterone acetate on carbohydrate metabolism. Obstet Gynecol 43:685-692, 1974
52. Carrington LJ, Bailey CJ: Effects of natural and synthetic estrogens and progestins on glycogen deposition in female mice. Horm Res 21:199-203, 1985
53. Puah JA, Bailey CJ: Effect of ovarian hormones on glucose metabolism in mouse soleus muscle. Endocrinology 117:1336-1340, 1985
54. Rushakoff RJ, Kalkhoff RK: Effects of pregnancy and sex steroid administration on skeletal muscle metabolism in the rat. Diabetes 30:545, 1981
55. Shadoan MK, Zhang L, Wagner JD: The progestin, medroxyprogesterone acetate, impairs insulin sensitivity in isolated adipocytes, independent of body composition. Diabetes 49:947, 2000 (abstr)
56. Sutter-Dub MT, Kaaya A, Sfaxi A, et al: Progesterone and synthetic steroids produce insulin resistance at the post-receptor level in adipocytes of female rats. Steroids 52:583-608, 1988
57. Selman PJ, Wolfswinkel J, Mol JA: Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Steroids 61:133-137, 1996
58. Goldman JA, Ovadia JL: The effect of estrogen on intravenous glucose tolerance in women. Am J Obstet Gynecol 103:172-178, 1969
59. Goldsland IF, Gangar K, Walton C, et al: Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42:846-853, 1993
60. Stevenson JC, Crook D, Godsland IF, et al: Oral versus transdermal hormone replacement therapy. Int J Fertil Menopausal Stud 38:30-35, 1993 (suppl 1)
61. Cagnacci A, Soldani R, Carriero PL, et al: Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74:1396-1400, 1992
62. Deng H-W, Li J, Li J-L, et al: Association of estrogen receptor-α genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 85:2748-2751, 2000
63. Toth MJ, Tchernof A, Sites CK, et a: Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 24:226-231, 2000
64. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208, 1995
65. Lobo RA, Pickar JH, Wild RA, et al: Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group. Obstet Gynecol 84:987-995, 1994
66. Friday KE, Dong C, Fontenot RU: Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 46:48-52, 2001
67. Lobo RA, Bush T, Carr BR, et al: Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 76:13-24, 2001
68. Manning PJ, Allum A, Jones S, et al: The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes. Arch Intern Med 161:1772-1776, 2001
69. Samaras K, Hayward CS, Sullivan D, et al: Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes. Diabetes Care 22:1401-1407, 1999
70. Lilley SH, Spivey JM, Vadlamudi S, et al: Lipid and lipoprotein responses to oral combined hormone replacement therapy in normolipemic obese women with controlled type 2 diabetes mellitus. J Clin Pharmacol 38:1107-1115, 1998
71. Manwaring P, Morfis L, Diamond T, et al: The effects of hormone replacement therapy on plasma lipids in type II diabetes. Maturitas 34:239-247, 2000
72. Notelovitz M: Metabolic effect of conjugated oestrogens (USP) on glucose tolerance. S Afr Med J 48:2599-2603, 1974
73. Colacurci N, Zarcone R, Mollo A, et al: Effects of hormone replacement therapy on glucose metabolism. Panminerva Med 40: 18-21, 1998
74. Saglam K, Polat Z, Yilmaz MI, et al: Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 18:211-214, 2002
75. Kanaya AM, Herrington D, Vittinghoff E, et al: Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:1-9, 2003
76. Grover-Paez F, Martinez-Abundis E, Gonzalez-Ortiz M: Effect of hormone replacement therapy including a progestin on insulin sensitivity and lipid profile in postmenopausal women. Rev Med Chil 129:989-994, 2001
77. Graczykowski JW, Wang C-Y, Stanczyk FZ, et al: The effect of medroxyprogesterone acetate on insulin sensitivity in post-menopausal women on estrogen replacement therapy. Endocrinol Fertil Forum 19:4, 1996 (abstr)
78. Shively CA, Clarkson TB, Miller LC, et al: Body fat distribution as a risk factor for coronary artery atherosclerosis in female cynomolgus monkeys. Arteriosclerosis 7:226-231, 1987
79. Shadoan MK, Rankin SE, Anthony MS, et al: Tibolone increases lean mass and bone mineral density in cynomolgus monkeys. FASEB J 15:A595, 2001 (abstr)